Current Report Filing (8-k)
June 05 2014 - 3:15PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): May 31, 2014
QLT Inc.
(Exact Name of
Registrant as specified in its charter)
|
|
|
|
|
British Columbia, Canada |
|
000-17082 |
|
N/A |
(State or Other Jurisdiction of
Incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
887 Great Northern Way, Suite 250, Vancouver, B.C.
Canada, V5T 4T5
(Address
of principal executive offices)
Registrants telephone number, including area code: (604) 707-7000
Not Applicable
(Registrants name or former address, if change since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
|
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers.
As previously disclosed, on December 18, 2013, QLT Inc. (the Company)
entered into a letter agreement with Alexander R. Lussow, the Companys Senior Vice President, Business Development and Commercial Operations, in which the Company, among other things, agreed that it would terminate Mr. Lussow on either,
in the Companys discretion, March 31, 2014, April 30, 2014 or May 31, 2014. Mr. Lussow was terminated effective May 31, 2014. As a result of the termination of his employment, Mr. Lussow will receive certain
severance benefits in accordance with the Change of Control Agreement, dated June 30, 2006, between the Company and Mr. Lussow, and the letter agreement, dated December 16, 2013, between the Company and Mr. Lussow. As a condition
to his receipt of benefits under the Change of Control Agreement and letter agreement, Mr. Lussow executed a release of all claims against the Company.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.
|
|
|
QLT INC. |
|
|
By: |
|
/s/ Sukhi
Jagpal |
Name: |
|
Sukhi Jagpal |
Title: |
|
Chief Financial Officer |
Date: June 5, 2014
Novelion Therapeutics (NASDAQ:NVLN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novelion Therapeutics (NASDAQ:NVLN)
Historical Stock Chart
From Apr 2023 to Apr 2024